Library · Reproductive · Prostate health regulation and maintenance
Prostamax (Lys-Glu-Asp-Pro)
KEDP, Lys-Glu-Asp-Pro tetrapeptide, Prostate peptide bioregulator
A synthetic tetrapeptide (Lys-Glu-Asp-Pro) studied as a bioregulator for prostate health, aimed at reducing inflammation and supporting gland function in conditions like BPH or prostatitis by influencing gene expression in prostate tissue.
Research score 35/100. Reference only, not a dose.
- Hormone Regulation
- Anti-inflammatory
- Healing
- Immune Boosting
- US status
- Research Chemical
- Approval
- Research Chemical Only
- Evidence
- Preclinical/Russian data. No FDA approval or Western clinical trials found.
- Research score
- 35 / 100
- Indication
- Research Only - No Medical Indication
- Origin
- Russia
- Source category
- Reproductive System
- Status group
- Research chemical
Mechanism
Modulates androgen-receptor signaling and prostate cell growth, acting through membrane receptors that trigger pathways controlling inflammation and tissue-specific protein synthesis, including PI3K/Akt and PSA-related transcription factors.
Safety file
Human safety data are lacking; presumed low toxicity based on its peptide class.
- Injection site reactions
- Mild fatigue
- Temporary hormone fluctuations